Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Canadian-led study identifies which colon cancer patients benefit from chemotherapy

17.07.2003


New insight is important step forward in personalized cancer care

A new Canadian-led study in the latest issue of the New England Journal of Medicine shows that a simple genetic test can determine if chemotherapy will be effective in treating a patient’s colon cancer, the second leading cause of cancer deaths in North America.
The study, led by doctors and researchers from Toronto’s Princess Margaret Hospital and Mount Sinai Hospital, examined 570 tissue samples from colon cancer patients. Colon cancer, which will kill an estimated 8,300 Canadians this year, is usually treated by a combination of surgery and chemotherapy.


The study determined that patients with a specific mutation in their tumor, called high-frequency microsatellite instability, did not benefit from chemotherapy, which can be a very difficult treatment with significant unpleasant side effects. The study’s findings represent a significant step forward in providing individualized treatment plans for colon cancer patients.

"This study shows that the usual type of chemotherapy is effective for about 83 per cent of colon cancer patients," said lead author Dr. Steven Gallinger, a surgical oncologist at Mount Sinai Hospital and University Health Network, as well as Professor of Surgery at University of Toronto. "Yet, for nearly 17 per cent of colon cancer patients, the traditional chemotherapy treatment is not helpful, and may even be harmful."

The study, which also involved doctors and researchers from the United States and France, shows that further investigation is needed to provide alternatives for these patients, such as new drugs that are effective on tumors with high-frequency microsatellite instability.

Testing for this genetic mutation could easily become a regular routine during diagnosis, with the results being used to direct the rational use of chemotherapy in colon cancer.

"Undergoing chemotherapy is not an easy decision. Side effects can include sore throat and mouth, tiredness, increased risk of infection, and in a small number of cases, even serious life-threatening illness," said Dr. Malcolm Moore, a Princess Margaret Hospital medical oncologist involved in the study. "If we can select the patients most likely to benefit from therapy, we can restrict therapy to that population and spare the remaining patients the trauma of that type of treatment."

Vince Rice | EurekAlert!
Further information:
http://www.utoronto.ca

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>